|
1
|
Rao SN and Smallridge RC: Anaplastic
thyroid cancer: An update. Best Pract Res Clin Endocrinol Metab.
37(101678)2023.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Fagin JA and Wells SA Jr: Biologic and
clinical perspectives on thyroid cancer. N Engl J Med.
375(2307)2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Fahiminiya S, de Kock L and Foulkes WD:
Biologic and clinical perspectives on thyroid cancer. N Engl J Med.
375:2306–2307. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Jung CK, Bychkov A and Kakudo K: Update
from the 2022 World Health Organization Classification of Thyroid
Tumors: A standardized diagnostic approach. Endocrinol Metab
(Seoul). 37:703–718. 2022.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Molinaro E, Romei C, Biagini A, Sabini E,
Agate L, Mazzeo S, Materazzi G, Sellari-Franceschini S, Ribechini
A, Torregrossa L, et al: Anaplastic thyroid carcinoma: From
clinicopathology to genetics and advanced therapies. Nat Rev
Endocrinol. 13:644–660. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Smallridge RC, Ain KB, Asa SL, Bible KC,
Brierley JD, Burman KD, Kebebew E, Lee NY, Nikiforov YE, Rosenthal
MS, et al: American Thyroid Association guidelines for management
of patients with anaplastic thyroid cancer. Thyroid. 22:1104–1139.
2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Wendler J, Kroiss M, Gast K, Kreissl MC,
Allelein S, Lichtenauer U, Blaser R, Spitzweg C, Fassnacht M,
Schott M, et al: Clinical presentation, treatment and outcome of
anaplastic thyroid carcinoma: Results of a multicenter study in
Germany. Eur J Endocrinol. 175:521–529. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Ragazzi M, Ciarrocchi A, Sancisi V,
Gandolfi G, Bisagni A and Piana S: Update on anaplastic thyroid
carcinoma: Morphological, molecular, and genetic features of the
most aggressive thyroid cancer. Int J Endocrinol.
2014(790834)2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Chiacchio S, Lorenzoni A, Boni G, Rubello
D, Elisei R and Mariani G: Anaplastic thyroid cancer: Prevalence,
diagnosis and treatment. Minerva Endocrinol. 33:341–357.
2008.PubMed/NCBI
|
|
10
|
Corrigan KL, Williamson H, Elliott Range
D, Niedzwiecki D, Brizel DM and Mowery YM: Treatment Outcomes in
Anaplastic Thyroid Cancer. J Thyroid Res.
2019(8218949)2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Guerra A, Di Crescenzo V, Garzi A, Cinelli
M, Carlomagno C, Tonacchera M, Zeppa P and Vitale M: Genetic
mutations in the treatment of anaplastic thyroid cancer: A
systematic review. BMC Surg. 13 (Suppl 2)(S44)2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Coca-Pelaz A, Rodrigo JP, Lopez F, Shah
JP, Silver CE, Al Ghuzlan A, Menke-van der Houven van Oordt CW,
Smallridge RC, Shaha AR, Angelos P, et al: Evaluating new
treatments for anaplastic thyroid cancer. Expert Rev Anticancer
Ther. 22:1239–1247. 2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Brauner E, Gunda V, Vanden Borre P,
Zurakowski D, Kim YS, Dennett KV, Amin S, Freeman GJ and Parangi S:
Combining BRAF inhibitor and anti PD-L1 antibody dramatically
improves tumor regression and anti tumor immunity in an
immunocompetent murine model of anaplastic thyroid cancer.
Oncotarget. 7:17194–17211. 2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Bible KC, Kebebew E, Brierley J, Brito JP,
Cabanillas ME, Clark TJ Jr, Di Cristofano A, Foote R, Giordano T,
Kasperbauer J, et al: 2021 American Thyroid Association guidelines
for management of patients with anaplastic thyroid cancer. Thyroid.
31:337–386. 2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Haymart MR, Banerjee M, Yin H, Worden F
and Griggs JJ: Marginal treatment benefit in anaplastic thyroid
cancer. Cancer. 119:3133–3139. 2013.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Orita Y, Sugitani I, Amemiya T and
Fujimoto Y: Prospective application of our novel prognostic index
in the treatment of anaplastic thyroid carcinoma. Surgery.
150:1212–1219. 2011.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Chintakuntlawar AV, Foote RL, Kasperbauer
JL and Bible KC: Diagnosis and Management of anaplastic thyroid
cancer. Endocrinol Metab Clin North Am. 48:269–284. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Koda K, Katoh M and Yasuhara K: Management
of anaplastic thyroid cancer and proposed treatment guidelines-A
5-year case series study. Cancer Rep (Hoboken).
5(e1727)2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Subbiah V, Kreitman RJ, Wainberg ZA, Cho
JY, Schellens JHM, Soria JC, Wen PY, Zielinski C, Cabanillas ME,
Urbanowitz G, et al: Dabrafenib and trametinib treatment in
patients with locally advanced or metastatic BRAF V600-Mutant
anaplastic thyroid cancer. J Clin Oncol. 36:7–13. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Hyman DM, Puzanov I, Subbiah V, Faris JE,
Chau I, Blay JY, Wolf J, Raje NS, Diamond EL, Hollebecque A, et al:
Vemurafenib in multiple nonmelanoma cancers with BRAF V600
Mutations. N Engl J Med. 373:726–736. 2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Brose MS, Smit JWA, Lin CC, Tori M, Bowles
DW, Worden F, Shen DH, Huang SM, Tsai HJ, Alevizaki M, et al:
Multikinase inhibitors for the treatment of asymptomatic
radioactive iodine-refractory differentiated thyroid cancer: Global
noninterventional study (RIFTOS MKI). Thyroid. 32:1059–1068.
2022.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Saini S, Tulla K, Maker AV, Burman KD and
Prabhakar BS: Therapeutic advances in anaplastic thyroid cancer: A
current perspective. Mol Cancer. 17(154)2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Crispo F, Notarangelo T, Pietrafesa M,
Lettini G, Storto G, Sgambato A, Maddalena F and Landriscina M:
BRAF inhibitors in thyroid cancer: Clinical impact, mechanisms of
resistance and future perspectives. Cancers (Basel).
11(1388)2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Cabanillas ME, Ferrarotto R, Garden AS,
Ahmed S, Busaidy NL, Dadu R, Williams MD, Skinner H, Gunn GB, Grosu
H, et al: Neoadjuvant BRAF- and immune-directed therapy for
anaplastic thyroid carcinoma. Thyroid. 28:945–951. 2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhao X, Wang JR, Dadu R, Busaidy NL, Xu L,
Learned KO, Chasen NN, Vu T, Maniakas A, Eguia AA, et al: Surgery
After BRAF-Directed Therapy is associated with improved survival in
BRAFV600E mutant anaplastic thyroid cancer: A single-center
retrospective cohort study. Thyroid. 33:484–491. 2023.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Niu Y, Ding Z, Deng X, Guo B, Kang J, Wu B
and Fan Y: A novel multimodal therapy for anaplastic thyroid
carcinoma: 125I seed implantation plus apatinib after
surgery. Front Endocrinol (Lausanne). 11(207)2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Xing Y, Wang Y and Wu X: Radiotherapy
combined with immunotherapy successfully treated one case of
anaplastic thyroid cancer: A case report. Front Oncol.
13(1125226)2023.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Ferrari SM, Elia G, Ragusa F, Ruffilli I,
La Motta C, Paparo SR, Patrizio A, Vita R, Benvenga S, Materazzi G,
et al: Novel treatments for anaplastic thyroid carcinoma. Gland
Surg. 9 (Suppl 1):S28–S42. 2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Oishi N, Kondo T, Ebina A, Sato Y, Akaishi
J, Hino R, Yamamoto N, Mochizuki K, Nakazawa T, Yokomichi H, et al:
Molecular alterations of coexisting thyroid papillary carcinoma and
anaplastic carcinoma: Identification of TERT mutation as an
independent risk factor for transformation. Mod Pathol.
30:1527–1537. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Khatami F and Tavangar SM: A review of
driver genetic alterations in thyroid cancers. Iran J Pathol.
13:125–135. 2018.PubMed/NCBI
|
|
31
|
Song YS and Park YJ: Genomic
characterization of differentiated thyroid carcinoma. Endocrinol
Metab (Seoul). 34:1–10. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Kasaian K, Wiseman SM, Walker BA, Schein
JE, Zhao Y, Hirst M, Moore RA, Mungall AJ, Marra MA and Jones SJ:
The genomic and transcriptomic landscape of anaplastic thyroid
cancer: Implications for therapy. BMC Cancer.
15(984)2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Man J, Nicolson N, Gibson C and Carling T:
TERT promoter mutations in thyroid cancer: Growing evidence for a
predictor of poor outcome. Gland Surg. 8:301–303. 2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Landa I and Knauf JA: Mouse models as a
tool for understanding progression in Braf V600E-Driven
thyroid cancers. Endocrinol Metab (Seoul). 34:11–22.
2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Pozdeyev N, Gay LM, Sokol ES, Hartmaier R,
Deaver KE, Davis S, French JD, Borre PV, LaBarbera DV, Tan AC, et
al: Genetic analysis of 779 advanced differentiated and anaplastic
thyroid cancers. Clin Cancer Res. 24:3059–3068. 2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Landa I, Pozdeyev N, Korch C, Marlow LA,
Smallridge RC, Copland JA, Henderson YC, Lai SY, Clayman GL, Onoda
N, et al: Comprehensive genetic characterization of human thyroid
cancer cell lines: A validated panel for preclinical studies. Clin
Cancer Res. 25:3141–3151. 2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Liu R and Xing M: TERT promoter mutations
in thyroid cancer. Endocr Relat Cancer. 23:R143–R155.
2016.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Ravi N, Yang M, Gretarsson S, Jansson C,
Mylona N, Sydow SR, Woodward EL, Ekblad L, Wennerberg J and
Paulsson K: Identification of targetable lesions in anaplastic
thyroid cancer by genome profiling. Cancers (Basel).
11(402)2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Hou P, Ji M and Xing M: Association of
PTEN gene methylation with genetic alterations in the
phosphatidylinositol 3-kinase/AKT signaling pathway in thyroid
tumors. Cancer. 113:2440–2447. 2008.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Alzahrani AS, Alsaadi R, Murugan AK and
Sadiq BB: TERT promoter mutations in thyroid cancer. Horm Cancer.
7:165–177. 2016.PubMed/NCBI View Article : Google Scholar
|
|
41
|
The AACR Project GENIE Consortium. AACR
Project GENIE: Powering precision medicine through an International
Consortium. Cancer Discov. 7:818–831. 2017.PubMed/NCBI View Article : Google Scholar
|
